Search results for "SID"

showing 10 items of 6756 documents

Prognosis factors in the treatment of bisphosphonate-related osteonecrosis of the jaw - Prognostic factors in the treatment of BRONJ -

2014

Objectives: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a relatively rare but serious side effect of bisphosphonate (BP)-based treatments. This retrospective study aimed to investigate the risk factors and predictive markers in cases where patients were refractory to a recommended conservative treatment offered in our hospital. Patients and Methods: This single-center study collated the medical records of all patients treated for BRONJ between 2004 and 2011. A complete medical history, including detailed questionnaires, was collected for all patients, focusing on identifying underlying risk factors, clinical features, location and bone marker levels of BRONJ. Results: The mea…

medicine.medical_specialtySide effectbusiness.industryMedical recordmedicine.medical_treatmentResearchRetrospective cohort studyOdontologíaBisphosphonatemedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSurgeryN-terminal telopeptideInternal medicineUNESCO::CIENCIAS MÉDICASMedicineMedical historyOral SurgerybusinessOsteonecrosis of the jawGeneral DentistryProgressive disease
researchProduct

Tratamiento integral de la dislipidemia diabética: beneficios y nuevas alternativas terapéuticas

2010

Diabetic dyslipidemia, characterized by the lipid triad (elevated plasma triglycerides, low HDL cholesterol and predominance of small, dense LDL particles), is a significant contributor to the elevated cardiovascular risk of type 2 diabetic patients. Statin monotherapy has shown, in different prospective trials, significant reductions in cardiovascular events and mortality. However, the residual risk in these subjects remains elevated, probably due to the incomplete control of diabetic dyslipidemia. In this review we discuss the global therapeutic approach, underlying the need of combining statins with agents that more effective in reducing triglycerides and elevating HDL cholesterol, even …

medicine.medical_specialtySmall dense ldlStatinmedicine.diagnostic_testCholesterolbusiness.industrymedicine.drug_classnutritional and metabolic diseasesGeneral MedicineResidual riskClinical trialchemistry.chemical_compoundTherapeutic approachEndocrinologychemistryInternal medicineHypolipidemic AgentsmedicineCardiologylipids (amino acids peptides and proteins)Lipid profilebusinessMedicina Clínica
researchProduct

Health literacy of patients on oral anticoagulation treatment- individual and social determinants and effect on health and treatment outcomes

2021

Abstract Background Assessment health literacy in people with cardiovascular health problems would facilitate the development of appropriate health strategies for the care and reduction of complications associated with oral anticoagulation therapy. Aim: To evaluate the relationship between health literacy and health and treatment outcomes (concordance with oral anticoagulants, Normalized Ratio control and occurrence of complications) in patients with cardiovascular pathology. Methods Observational, analytic and cross-sectional study carried out on 252 patients with cardiovascular pathology (atrial fibrillation, flutter or valve prosthesis), aged 50–85 years, accessing primary care services …

medicine.medical_specialtySocial Determinants of HealthAdministration OralHealth literacy030204 cardiovascular system & hematologyRT1117 Public Health and Health ServicesTreatment adherence and compliance03 medical and health sciences0302 clinical medicineRA0421Atrial FibrillationEpidemiologySelf-managementmedicineHumansSalutAlfabetització030212 general & internal medicineSocial determinants of healthPublic Environmental & Occupational HealthDrug-related side effects and adverse reactionPolypharmacyAcenocoumarolScience & Technologybusiness.industryAcenocoumarolPublic healthPublic Health Environmental and Occupational HealthHealth literacyAnticoagulantsCAREHealth servicesCross-Sectional StudiesTreatment OutcomeSpainEmergency medicineHEART-FAILUREObservational studyPublic HealthPublic aspects of medicineRA1-1270BiostatisticsbusinessLife Sciences & BiomedicineResearch Articlemedicine.drugBMC Public Health
researchProduct

Models and Model Transformations Within Web Applications

2016

Unlike traditional single-user desktop applications, web applications have separated memory and computational resources (the client and the server side) and have to deal with multiple user accounts. This complicates the development process. Is there some approach of creating web applications without thinking about web-specific aspects, as if we are developing stand-alone desktop applications? We say, “yes”, and that is where models and model transformations come in handy. The proposed model-driven approach simplifies the development of web applications and makes it possible to use a single code base for deploying both desktop and web-based versions of the software.

medicine.medical_specialtySoftwarebusiness.industryComputer scienceProcess (engineering)medicineCode (cryptography)Web applicationBase (topology)Software engineeringbusinessWeb modelingServer-side
researchProduct

The Role of Erythropoietin in Aneurysmal Subarachnoid Haemorrhage: From Bench to Bedside

2014

Subarachnoid haemorrhage (SAH) caused by a ruptured aneurysm accounts for only 5 % of strokes, but occurs at a fairly young age and carries a poor prognosis. Delayed cerebral ischaemia (DCI) is an important cause of death and dependence after aneurysmal SAH. The current mainstay of preventing DCI is nimodipine and maintenance of normovolemia, but even with this strategy DCI occurs in a considerable proportion of patients.

medicine.medical_specialtySubarachnoid hemorrhagebusiness.industryVasospasmmedicine.diseaseBench to bedsidenervous system diseasesAneurysmErythropoietinInternal medicinemedicineCardiologySubarachnoid haemorrhagecardiovascular diseasesbusinessNimodipinemedicine.drugCause of death
researchProduct

Uveítis anterior aguda hipertensiva granulomatosa bilateral como efecto adverso a brimonidina tópica

2018

Abstract Clinical case The case concerns an 81-year-old woman on treatment with a topical fixed combination of timolol and brimonidine who was diagnosed in the Emergency Department with acute anterior granulomatous hypertensive uveitis. The patient responded favorably to the withdrawal of the eye drops without showing any subsequent relapse. Discussion Uveitis due to brimonidine is a rare adverse effect, but it must be known. Once the diagnosis is suspected, the effective treatment is the withdrawal of brimonidine, with or without the addition of topical corticosteroids to control inflammation depending on the severity of the condition. It is a process with an excellent prognosis.

medicine.medical_specialtySubsequent RelapseSide effectbusiness.industryBrimonidineTimololEmergency departmentmedicine.diseaseDermatology03 medical and health sciencesOphthalmology0302 clinical medicine030221 ophthalmology & optometrymedicineAnterior uveitisAdverse effectbusiness030217 neurology & neurosurgeryUveitismedicine.drugArchivos de la Sociedad Española de Oftalmología
researchProduct

Diagnostic efficacy of the fluorometric determination of enzyme activity for Pompe disease from dried blood specimens compared with lymphocytes-possi…

2009

Pompe disease is a rare, autosomal-recessive disorder which results from a defect in the lysosomal enzyme acid alpha-glucosidase (GAA). The onset of this disease is highly variable, with infantile types being the most severe. Traditionally, lymphocytes, fibroblasts or muscle biopsies were necessary for enzyme activity measurement, because these materials do not express maltase-glucoamylase (MGA) that interferes with the assay. Recently, acarbose was found to inhibit MGA activity selectively, so that dried blood became accessible for GAA assessment.To evaluate the diagnostic efficacy of GAA measurement in dried blood specimens (DBSs) in comparison with lymphocytes. If DBSs provided reliable …

medicine.medical_specialtyTime FactorsLymphocyteBiopsyNeonatal ScreeningInternal medicineBiopsyGeneticsmedicineHumansFalse Positive ReactionsFluorometryLymphocytesGenetics (clinical)Acarbosechemistry.chemical_classificationNewborn screeningmedicine.diagnostic_testbiologybusiness.industryGlycogen Storage Disease Type IIMusclesInfant NewbornReproducibility of Resultsalpha-GlucosidasesEnzyme replacement therapyFibroblastsHydrogen-Ion ConcentrationEnzyme assaymedicine.anatomical_structureEndocrinologyEnzymechemistryCarbohydrate Metabolism Disorderbiology.proteinFeasibility Studiesbusinessmedicine.drugJournal of inherited metabolic disease
researchProduct

Coronary stent implantation in acute vessel closure 48 hours after an unsatisfactory coronary angioplasty

1990

We report the implantation of a balloon-expandable stent in a patient with acute vessel closure in the state of evolving myocardial infarction following 48 hr after unsatisfactory coronary angioplasty. The stent was implanted after successful recanalization of an occluded left anterior descending artery, with repeated unsatisfactory results of balloon angioplasty. Adjunct thrombolytic therapy was contraindicated. No residual stenosis was documented in immediate control angiograms, or after 24 hr, 3 weeks, and 4 months.

medicine.medical_specialtyTime Factorsmedicine.medical_treatmentCoronary DiseaseCoronary AngiographyBalloonAngioplastyInternal medicineCoronary stentmedicineHumansAngina Unstablecardiovascular diseasesMyocardial infarctionAngioplasty Balloon Coronarybusiness.industryStentResidual stenosisMiddle Agedmedicine.diseaseCoronary VesselsSurgerymedicine.anatomical_structureCardiologyStentsCardiology and Cardiovascular MedicineComplicationbusinessArteryCatheterization and Cardiovascular Diagnosis
researchProduct

Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial.

2021

Aims Despite aortic stenosis (AS) relief, patients undergoing transcatheter aortic valve implantation (TAVI) are at increased risk of developing heart failure (HF) within first months of intervention. Sodium-glucose co-transporter 2 (SGLT-2) inhibitors have been shown to reduce the risk of HF hospitalization in individuals with diabetes mellitus (DM), reduced left ventricular ejection fraction (LVEF) and chronic kidney disease (CKD). However, the effect of SGLT-2 inhibitors on outcomes after TAVI is unknown. The Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) trial is designed to assess the clinical benefit and safety of the SGLT-2 inhibitor dapagliflozin in patients …

medicine.medical_specialtyTranscatheter aorticVentricular Function Leftlaw.inventionTranscatheter Aortic Valve Replacementchemistry.chemical_compoundRandomized controlled trialGlucosideslawInternal medicineDiabetes mellitusmedicineHumansProspective StudiesDapagliflozinBenzhydryl CompoundsHeart FailureEjection fractionbusiness.industryStroke VolumeAortic Valve Stenosismedicine.diseaseStenosisTreatment OutcomechemistryHeart failureAortic ValveCardiologyCardiology and Cardiovascular MedicinebusinessKidney diseaseEuropean journal of heart failureReferences
researchProduct

Correspondence relating to the paper “Right-sided infective endocarditis: insights into the forgotten valve”

2019

medicine.medical_specialtyTricuspid valveEndocarditisbusiness.industryEndocarditis Bacterialmedicine.diseasemedicine.disease_causeSurgeryRight sided infective endocarditismedicine.anatomical_structureStaphylococcus aureusInfective endocarditisHumansMedicineCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct